Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation
Clinical trial NCT06425276 · COMPLETED
Trial details
- NCT number
- NCT06425276
- Sponsor
- CASI Pharmaceuticals (China) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-24
- Primary completion
- 2021-07-08
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.